What's Happening in Health: RNA treatment for brain cancer
UC research examines use of microbubbles, RNA for targeted brain tumor treatment
UC scientists are conducting research that could bring hope to those diagnosed with brain cancer.
Daniel Pomeranz Krummel, PhD, research associate professor at UC and author on a new study, was a guest on Local 12's What's Happening in Health, discussing a new RNA treatment being studied for brain tumors.
"We're developing a novel therapeutic approach that will help us treat adult and pediatric brain tumors," he says.
Watch the full interview (Note: Interview starts at around the 5:55 minute mark).
Soma Sengupta, MD, PhD, associate director of the UC Gardner Neuroscience Institute’s Brain Tumor Center, was also involved in this research and was interviewed by WCPO, Channel 9.
Read more about the study on UC News.
Featured photo of a brain courtesy of Unsplash.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up to date on all UC's COVID-19 stories, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
Meet the young talent reshaping Cincinnati’s startup scene
October 28, 2025
Five University of Cincinnati students were honored for their impactful entrepreneurship on the Cincy Inno Under 25 list. We’ll explain what makes each student – and their startup – stand out.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.